The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

PubWeight™: 9.89‹?› | Rank: Top 0.1%

🔗 View Article (PMC 3267575)

Published in Nature on January 11, 2012

Authors

Jinghui Zhang1, Li Ding, Linda Holmfeldt, Gang Wu, Sue L Heatley, Debbie Payne-Turner, John Easton, Xiang Chen, Jianmin Wang, Michael Rusch, Charles Lu, Shann-Ching Chen, Lei Wei, J Racquel Collins-Underwood, Jing Ma, Kathryn G Roberts, Stanley B Pounds, Anatoly Ulyanov, Jared Becksfort, Pankaj Gupta, Robert Huether, Richard W Kriwacki, Matthew Parker, Daniel J McGoldrick, David Zhao, Daniel Alford, Stephen Espy, Kiran Chand Bobba, Guangchun Song, Deqing Pei, Cheng Cheng, Stefan Roberts, Michael I Barbato, Dario Campana, Elaine Coustan-Smith, Sheila A Shurtleff, Susana C Raimondi, Maria Kleppe, Jan Cools, Kristin A Shimano, Michelle L Hermiston, Sergei Doulatov, Kolja Eppert, Elisa Laurenti, Faiyaz Notta, John E Dick, Giuseppe Basso, Stephen P Hunger, Mignon L Loh, Meenakshi Devidas, Brent Wood, Stuart Winter, Kimberley P Dunsmore, Robert S Fulton, Lucinda L Fulton, Xin Hong, Christopher C Harris, David J Dooling, Kerri Ochoa, Kimberly J Johnson, John C Obenauer, William E Evans, Ching-Hon Pui, Clayton W Naeve, Timothy J Ley, Elaine R Mardis, Richard K Wilson, James R Downing, Charles G Mullighan

Author Affiliations

1: Department of Computational Biology and Bioinformatics, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Associated clinical trials:

Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | NCT00137111

Articles citing this

(truncated to the top 100)

Signatures of mutational processes in human cancer. Nature (2013) 21.63

Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell (2012) 6.09

The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer (2012) 4.97

Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell (2012) 4.41

Identification of early replicating fragile sites that contribute to genome instability. Cell (2013) 3.99

Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat Med (2014) 3.75

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet (2013) 3.51

Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51

Epigenetic reprogramming in cancer. Science (2013) 3.47

Acute lymphoblastic leukaemia. Lancet (2013) 3.44

The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43

Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. Eur Urol (2012) 3.20

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet (2014) 3.17

The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest (2012) 3.09

Interplay between the cancer genome and epigenome. Cell (2013) 3.05

The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSα. Cell (2013) 2.87

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood (2012) 2.82

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy. Nature (2014) 2.81

RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet (2014) 2.72

Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. Nat Med (2013) 2.67

Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet (2012) 2.64

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors. Cancer Discov (2014) 2.64

Chromatin proteins and modifications as drug targets. Nature (2013) 2.60

Emerging patterns of somatic mutations in cancer. Nat Rev Genet (2013) 2.50

Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA (2012) 2.49

The Pediatric Cancer Genome Project. Nat Genet (2012) 2.49

C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature (2014) 2.44

Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet (2015) 2.44

The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. Nat Genet (2015) 2.34

AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes. Cancer Cell (2014) 2.33

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. Cell Rep (2014) 2.27

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network. Clin Cancer Res (2013) 2.26

The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell (2013) 2.24

CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance. Cancer Cell (2015) 2.20

The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. Immunity (2012) 2.15

End-joining, translocations and cancer. Nat Rev Cancer (2013) 2.13

Activation of proto-oncogenes by disruption of chromosome neighborhoods. Science (2016) 2.11

Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood (2012) 2.09

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst (2012) 2.09

A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nat Med (2014) 2.08

Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nat Genet (2014) 1.94

The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes. Nat Commun (2014) 1.90

Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia. Cell (2014) 1.88

Zebrafish cancer: the state of the art and the path forward. Nat Rev Cancer (2013) 1.87

Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood (2013) 1.87

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet (2013) 1.87

The mutational landscape of adenoid cystic carcinoma. Nat Genet (2013) 1.83

Clonal evolution enhances leukemia-propagating cell frequency in T cell acute lymphoblastic leukemia through Akt/mTORC1 pathway activation. Cancer Cell (2014) 1.79

Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood (2012) 1.78

Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat Genet (2013) 1.77

A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev (2012) 1.75

The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemia. Blood (2014) 1.75

Targeting oxidative stress in embryonal rhabdomyosarcoma. Cancer Cell (2013) 1.72

Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet (2013) 1.71

Cyclin C is a haploinsufficient tumour suppressor. Nat Cell Biol (2014) 1.68

Targeting oncogenic Ras signaling in hematologic malignancies. Blood (2012) 1.67

Molecular pathogenesis of chronic lymphocytic leukemia. J Clin Invest (2012) 1.64

Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov (2014) 1.63

Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev (2013) 1.62

An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell (2012) 1.61

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia. Blood (2015) 1.60

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature (2014) 1.60

SETD2-dependent histone H3K36 trimethylation is required for homologous recombination repair and genome stability. Cell Rep (2014) 1.57

Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet (2015) 1.57

Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. Cell Stem Cell (2013) 1.56

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases. J Hematol Oncol (2012) 1.56

Loss of oncogenic Notch1 with resistance to a PI3K inhibitor in T-cell leukaemia. Nature (2014) 1.55

Cancer genome-sequencing study design. Nat Rev Genet (2013) 1.55

Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proc Natl Acad Sci U S A (2012) 1.52

Targeting EZH2 in cancer. Nat Med (2016) 1.51

Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature (2014) 1.47

The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing. Hum Mutat (2015) 1.46

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse. Nat Genet (2013) 1.45

Dual Chromatin and Cytoskeletal Remodeling by SETD2. Cell (2016) 1.44

NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function. Mol Cell (2012) 1.44

Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell (2012) 1.43

Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest (2012) 1.38

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci U S A (2014) 1.36

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. Blood (2014) 1.36

The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat Immunol (2013) 1.35

PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet (2014) 1.34

Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer. Mol Cell (2012) 1.34

Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia. Am J Blood Res (2013) 1.33

Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia. Nat Commun (2014) 1.33

SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint. Elife (2014) 1.33

A 50-year journey to cure childhood acute lymphoblastic leukemia. Semin Hematol (2013) 1.32

A complex Polycomb issue: the two faces of EZH2 in cancer. Genes Dev (2012) 1.32

Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements. Nat Med (2012) 1.32

Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease. J Clin Oncol (2014) 1.31

Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia. PLoS Genet (2013) 1.29

Sherlock: detecting gene-disease associations by matching patterns of expression QTL and GWAS. Am J Hum Genet (2013) 1.29

Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia. Pediatr Blood Cancer (2012) 1.29

Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia. Blood (2015) 1.26

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol (2015) 1.26

RUNX1 is a key target in t(4;11) leukemias that contributes to gene activation through an AF4-MLL complex interaction. Cell Rep (2013) 1.22

Genome-wide characterization of pancreatic adenocarcinoma patients using next generation sequencing. PLoS One (2012) 1.21

Chromatin signatures of cancer. Genes Dev (2015) 1.20

Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia. J Clin Invest (2013) 1.19

Genomic characterization of childhood acute lymphoblastic leukemia. Semin Hematol (2013) 1.19

Articles cited by this

Circos: an information aesthetic for comparative genomics. Genome Res (2009) 40.02

Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 18.84

Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 16.72

The Polycomb complex PRC2 and its mark in life. Nature (2011) 11.97

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet (2010) 10.97

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med (2009) 10.54

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell (1996) 9.74

Acute lymphoblastic leukaemia. Lancet (2008) 8.54

Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell (2011) 7.03

CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat Methods (2011) 5.34

Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med (2011) 5.24

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol (2009) 4.89

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet (2009) 4.35

Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science (2011) 3.89

Launching the T-cell-lineage developmental programme. Nat Rev Immunol (2008) 3.86

Array-based genomic resequencing of human leukemia. Oncogene (2010) 3.77

Reverse engineering cellular networks. Nat Protoc (2006) 3.67

Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood (2009) 3.50

Adult T-cell progenitors retain myeloid potential. Nature (2008) 3.41

Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet (2000) 3.39

Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med (2008) 3.24

Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol (2006) 2.69

PHF6 mutations in T-cell acute lymphoblastic leukemia. Nat Genet (2010) 2.66

Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. Blood (2004) 2.60

Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med (2011) 2.59

TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia (1995) 2.54

ETV6: a versatile player in leukemogenesis. Semin Cancer Biol (2005) 2.24

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group. J Clin Oncol (2011) 2.11

Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia. Oncogene (2005) 1.96

Molecular genetics of human leukemias: new insights into therapy. Semin Hematol (2002) 1.91

WT1 mutations in T-ALL. Blood (2009) 1.75

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes. BMC Cancer (2008) 1.66

Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML. Leukemia (2010) 1.65

From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation. Immunol Rev (2010) 1.60

Dynamin 2 and human diseases. J Mol Med (Berl) (2010) 1.59

An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood (1993) 1.58

Activating mutations in human acute megakaryoblastic leukemia. Blood (2008) 1.56

Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk Res (1999) 1.54

Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome. J Clin Endocrinol Metab (2005) 1.22

Activating FLT3 mutations in CD4+/CD8- pediatric T-cell acute lymphoblastic leukemias. Blood (2005) 1.21

MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell context. Haematologica (2010) 1.16

Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases. Int J Hematol (1998) 1.02

Articles by these authors

Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09

MicroRNA expression profiles classify human cancers. Nature (2005) 69.12

An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35

Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res (2005) 44.08

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09

DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature (2008) 38.13

Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med (2009) 33.09

Whole-genome sequencing and variant discovery in C. elegans. Nat Methods (2008) 31.92

Mapping and sequencing of structural variation from eight human genomes. Nature (2008) 30.28

Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature (2006) 24.52

Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74

Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med (2002) 20.68

International network of cancer genome projects. Nature (2010) 20.35

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87

Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature (2010) 19.68

The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73

BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods (2009) 18.41

Evolution of genes and genomes on the Drosophila phylogeny. Nature (2007) 18.01

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature (2007) 17.68

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res (2006) 17.42

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell (2005) 17.41

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48

Evolutionary and biomedical insights from the rhesus macaque genome. Science (2007) 16.21

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12

VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics (2009) 16.04

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res (2012) 15.90

Extending assembly of short DNA sequences to handle error. Bioinformatics (2007) 14.46

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature (2012) 14.33

Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29

DNMT3A mutations in acute myeloid leukemia. N Engl J Med (2010) 14.07

The genome sequence of Caenorhabditis briggsae: a platform for comparative genomics. PLoS Biol (2003) 13.32

Mapping copy number variation by population-scale genome sequencing. Nature (2011) 12.55